HIV-1 residual risk and pre-treatment drug resistance among blood donors: A sentinel surveillance from Gabon
C Mangala, D Takou, D Maulot-Bangola, G Beloumou… - Plos one, 2024 - journals.plos.org
Background Surveillance of HIV-1 pre-treatment drug resistance (PDR) is essential for
ensuring the success of first-line antiretroviral therapy (ART). Beside population-based …
ensuring the success of first-line antiretroviral therapy (ART). Beside population-based …
Genetic diversity of the human immunodeficiency virus of type 1 in Gabonese transfusional settings
C Mangala, J Fokam, D Maulot-Bangola… - BMC Infectious …, 2023 - Springer
Background The high endemicity of transfusion-transmissible infections (TTIs) in sub-
Saharan Africa is a real public health problem. To reduce the risk of HIV transmission …
Saharan Africa is a real public health problem. To reduce the risk of HIV transmission …
Residual risk of HIV in African transfusional setting: Systematic review and meta-analysis
T Nkoa, M Moundanga, DM Bangola… - … STD Research & …, 2021 - info.submit4journal.com
Context: The residual risk of HIV transmission is still a real problem into the transfusional
settings of limited resources countries. Blood banks of African countries confront the risk of …
settings of limited resources countries. Blood banks of African countries confront the risk of …
Genetic Diversity of HIV-1 and Transfusion Safety: Systematic Review and Concepts Analysis
T Nkoa, DM Bangola, J Fokam… - … STD Research & …, 2021 - info.submit4journal.com
Background: The genetic diversity of human immunodeficiency virus type 1 (HIV-1) is a real
problem facing blood banks. This genetic diversity has a negative impact on diagnostic …
problem facing blood banks. This genetic diversity has a negative impact on diagnostic …
[引用][C] Evaluation of rapid diagnostic test method for screening blood donors and determining the risk of transfusion transmitted viral infections in selected health …
PK Boah - 2019 - University of Ghana